Identification of the Epigenetic Reader BRD4 As a Novel Therapeutic Target in JAK2 V617F+MPN Cells

被引：0
|
作者：
Keller, Alexandra [1 ,2 ]
Peter, Barbara [1 ,2 ]
Zuber, Johannes [3 ]
Staber, Philipp Bernhard [2 ]
Bettelheim, Peter [4 ]
Valent, Peter [1 ,2 ]
Hadzijusufovic, Emir [1 ,2 ,5 ]
机构：
[1] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria
[2] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria
[3] Res Inst Mol Pathol IMP, Vienna, Austria
[4] Elisabethinen Hosp, Dept Med 1, Linz, Austria
[5] Univ Vet Med Vienna, Internal Med, Small Anim Clin, Dept Compan Anim & Horses, Vienna, Austria
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] TARGETING OF BRD4 AS A NOVEL THERAPEUTIC CONCEPT IN JAK2 V617F+MPN
    Keller, A.
    Peter, B.
    Zuber, J.
    Berger, D.
    Staber, P. B.
    Bettelheim, P.
    Valent, P.
    Hadzijusufovic, E.
    [J]. HAEMATOLOGICA, 2016, 101 : 89 - 89
  • [2] Evaluation of BRD4 as potential target in JAK2 V617F+MPN cells
    Keller, A.
    Peter, B.
    Zuber, J.
    Valent, P.
    Hadzijusufovic, E.
    [J]. Oncology Research and Treatment, 2015, 38 : 226 - 227
  • [3] Identification of the Epigenetic Reader BRD4 As a Novel Potential Target in Ph plus CML
    Peter, Barbara
    Eisenwort, Gregor
    Stefanzl, Gabriele
    Berger, Daniela
    Sperr, Wolfgang R.
    Zuber, Johannes
    Valent, Peter
    [J]. BLOOD, 2015, 126 (23)
  • [4] ACTIVATED STAT5 AS NOVEL STEM TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Hoermann, G.
    Mayerhofer, M.
    Boudot, C.
    Gouilleux, F.
    Muellauer, L.
    Moriggl, R.
    Valent, P.
    [J]. HAEMATOLOGICA, 2015, 100 : 524 - 525
  • [5] Validation of the Epigenetic Reader and Histone Acetyltransferase BRD4 as a Therapeutic Target in a Murine Colitis Model
    Tian, Bing
    Villeger, Romain
    Liu, Ziqing
    Chen, Haiying
    Zhou, Jia
    Pinchuk, Irina
    Brasier, Allan
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S86 - S86
  • [6] Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patients
    Pearson, Stella
    Blance, Rognvald
    Yan, Fei
    Hsieh, Ya-Ching
    Geary, Bethany
    Amaral, Fabio M. R.
    Somervaille, Tim C. P.
    Kirschner, Kristina
    Whetton, Anthony D. D.
    Pierce, Andrew
    [J]. PLOS ONE, 2023, 18 (05):
  • [7] Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling
    Brasier, Allan R.
    Zhou, Jia
    [J]. DRUG DISCOVERY TODAY, 2020, 25 (01) : 126 - 132
  • [8] JAK2 haplotype 46/1 and JAK2 V617F allele burden in MPN: New evidence against the "hypermutability" hypothesis?
    Stolyar, M. A.
    Klimova, O. A.
    Gorbenko, A. S.
    Brenner, E. V.
    Titov, S. E.
    Ivanov, M. K.
    Olkhovskiy, I. A.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : E8 - E10
  • [9] Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients
    Lange, Thoralf
    Edelmann, Anja
    Siebolts, Uwe
    Nehring, Claudia
    Jaeckel, Nadja
    Cross, Michael
    Jacqueline, Maier
    Niederwieser, Dietger
    Wickenhauser, Claudia
    [J]. BLOOD, 2010, 116 (21) : 1421 - 1421
  • [10] 不同MPN JAK2～(V617F)突变的临床检测方法比较
    丁忠奇
    李毅
    郑国华
    [J]. 中国医学工程, 2013, 21 (05) : 96 - 97
12345